≡ Menu

Patents Kill: Apple Watch Blocked from Blood Oxygen Monitoring

For the latest in my “patents kill” series…

Apple to halt sales of some Apple Watches in US.

“The decision to take one of its most popular products off the shelf follows an ongoing dispute with medical device maker Masimo over its blood oxygen feature. Apple has routinely marketed its smartwatch as a life-saving device, which has helped launch the Apple Watch into the stratosphere, making it the most popular watch sold around the world. But its skirmish with Masimo threatens to undermine that.”

As I wrote to some friends: this is an example of how IP can kill. I mean sure, Apple ” can afford it” but … can everyone? Can Apple afford all of such things, at the margin? What about the chilling effect. So if a given watch doesn’t have an O2 monitor, out of millions of users, how many deaths might this cause? 1? 2? A half? It’s not zero. IP kills.

{ 0 comments… add one }

To the extent possible under law, Stephan Kinsella has waived all copyright and related or neighboring rights to C4SIF. This work is published from: United States. In the event the CC0 license is unenforceable a  Creative Commons License Creative Commons Attribution 3.0 License is hereby granted.